Candel Therapeutics, Inc. Detailed Financials
Full historical quarterly statements
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Goods Sold | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| R&D Expenses | 9.8M | 11.0M | 8.5M | 7.0M | 4.0M | 4.8M | 5.4M | 5.0M |
| Operating Expenses | 16.3M | 15.8M | 13.2M | 11.2M | 8.1M | 8.1M | 8.8M | 8.6M |
| Operating Income | -16.3M | -15.8M | -13.2M | -11.2M | -8.1M | -8.1M | -8.8M | -8.6M |
| Other Income / Gains | 7.4M | -13.7M | 1.9M | 6.4M | 15.5M | -5.9M | -1.9M | -13.7M |
| Net Income | -8.9M | -29.5M | -11.3M | -4.8M | 7.4M | -14.1M | -10.6M | -22.2M |
| EPS (Diluted) | -0.14 | -0.54 | -0.21 | -0.093 | 0.23 | -0.40 | -0.33 | -0.74 |
| Reported Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Gross Profit Ratio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General And Administrative Expenses | 6.4M | 4.7M | 4.7M | 4.2M | 4.1M | 3.3M | 3.3M | 3.6M |
| Selling And Marketing Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling General And Administrative Expenses | 6.4M | 4.7M | 4.7M | 4.2M | 4.1M | 3.3M | 3.3M | 3.6M |
| Other Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost And Expenses | 16.3M | 15.8M | 13.2M | 11.2M | 8.1M | 8.1M | 8.8M | 8.6M |
| Interest Income | 1.3M | 1.1M | 953K | 926K | 934K | 290K | 236K | 240K |
| Interest Expense | 1.6M | 1.4M | 161K | 236K | 306K | 390K | 487K | 567K |
| Depreciation And Amortization | 149K | 163K | 195K | 242K | 245K | 245K | 245K | 249K |
| Ebitda | -7.1M | -27.9M | -10.9M | -4.3M | 7.9M | -13.4M | -9.9M | -21.4M |
| Ebitdaratio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income Ratio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Before Tax | -8.9M | -29.5M | -11.3M | -4.8M | 7.4M | -14.1M | -10.6M | -22.2M |
| Income Before Tax Ratio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income Ratio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Epsdiluted | -0.14 | -0.54 | -0.21 | -0.093 | 0.23 | -0.40 | -0.33 | -0.74 |
| Weighted Average Shs Out | 62.4M | 54.9M | 54.9M | 51.5M | 31.7M | 35.6M | 32.0M | 29.9M |
| Weighted Average Shs Out Dil | 62.4M | 54.9M | 54.9M | 51.5M | 31.7M | 35.6M | 32.0M | 29.9M |